USPTO serial 99625238
IGNOTA LABS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- COLLIER, DAVID E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with IGNOTA LABS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LEIGH ANN LINDQUIST
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alloimmune diseases, alopecia, Alzheimer's disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, maternal fetal disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, ophthalmic diseases, opioid use disorder, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, pulmonary diseases, respiratory diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases, viral diseases, vision loss and urological diseases; pharmaceutical preparations for weight management; pharmaceutical preparations, namely, vaccines; veterinary preparations, namely, anti-inflammatories, insecticides, and hormone treatments, and preparations for treating parasites, viral infections, bacterial infections, fungal infections, cancer, respiratory diseases, urological disorders, diabetes, eye conditions, ear conditions, dermatitis, autoimmune disorders, pain, mastitis, neurological diseases, edema, and for promoting weight gain, in ruminants, porcines, equines, companion animals, aquaculture, and poultry; pharmaceutical preparations for the treatment of autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, viral, infectious, fungal, bacterial, and parasitic diseases and disorders for veterinary use; veterinary preparations, namely, vaccines for veterinary use for the treatment of ruminants, porcines, equines, companion animals, aquaculture, and poultry; veterinary preparations, namely, veterinary vaccines | ACTIVE | — |
| 009 | Downloadable computer software for accessing, browsing and searching online databases, in the field of drug research and pharmaceutical research; downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling, in the field of drug research and pharmaceutical research; downloadable computer software for data analysis for use in the field of drug rescue; downloadable computer software for data analysis for use in the field of drug research and pharmaceutical research; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the analysis of pharmaceuticals, medicines and clinical trials; downloadable artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling in the field of drug research and pharmaceutical research; downloadable artificial intelligence software for data analysis for use in the field of drug rescue; downloadable artificial intelligence software for data analysis for use in the field of drug research and pharmaceutical research; downloadable machine learning software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling in the field of drug research and pharmaceutical research; downloadable machine learning software for data analysis for use in the field of drug rescue; downloadable machine learning software for data analysis for use in the field of drug research and pharmaceutical research; downloadable data processing software in the field of drug research and pharmaceutical research; downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of machine learning; downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of artificial intelligence; downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of drug discovery; downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of drug research and pharmaceutical research; downloadable electronic publications in the nature of books, magazines, manuals and newsletters relating to the results of clinical trials; electronic downloadable publications in the nature of books, magazines, manuals and newsletters in the field of machine learning; electronic downloadable publications in the nature of books, magazines, manuals and newsletters in the field of artificial intelligence; electronic downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug discovery; electronic downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug research and pharmaceutical research; electronic downloadable publications in the nature of books, magazines, manuals and newsletters relating to the results of clinical trials | ACTIVE | — |
| 041 | non- downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of science; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of medicine; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of machine learning; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of artificial intelligence; non- downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of drug discovery; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of drug research and pharmaceutical research; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters relating to the results of clinical trials; providing on-line publications in the nature of books, magazines, manuals and newsletters in the field of science; on-line publication of electronic books and journals; non-downloadable electronic publications in the nature of books, magazines, manuals and newsletters in the field of medicine; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of machine learning; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of artificial intelligence; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug discovery; online non- downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug research and pharmaceutical research; online non-downloadable publications in the nature of books, magazines, manuals and newsletters relating to the results of clinical trials; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of machine learning; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of artificial intelligence; online non-downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug discovery; online non- downloadable publications in the nature of books, magazines, manuals and newsletters in the field of drug research and pharmaceutical research; online non-downloadable publications in the nature of books, magazines, manuals and newsletters relating to the results of clinical trials | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the field of drug research and pharmaceutical research; scientific and technological services, namely, scientific research, analysis and testing in the field of drug discovery; biochemical research, analysis and providing information in the field of biochemical research and analysis; biotechnology research; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the analysis of pharmaceuticals; providing online non-downloadable computer software for data analysis for use in the field of drug rescue; Platform as a Service (PaaS) featuring artificial intelligence computer software platforms for searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals; Platform as a Service (PaaS) featuring artificial intelligence computer software platforms for searching, tracking, exploration and analysis of data for use in the analysis of pharmaceuticals; Platform as a Service (PaaS), featuring artificial intelligence computer software platforms for searching, tracking, exploration and analysis of data for use in the field of drug rescue; Platform as a Service (PaaS) featuring artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of drug research; Software as a Service (SaaS) featuring artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of pharmaceuticals; Software as a Service (SaaS) featuring artificial intelligence software for searching, tracking, exploration and analysis of data for use in the analysis of pharmaceuticals; Software as a Service (SaaS) featuring artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of drug rescue; Software as a Service (SaaS) featuring artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of drug research; hosting of computer platforms on the Internet in the field of drug research and pharmaceutical research; writing of computer programs for biotechnological applications; scientific services, namely, scientific research and analysis in the field of drug discovery; Pharmacological services, namely, research, testing and development in the pharmaceutical field; Medical research and development in the field of drug discovery; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; biological research, clinical research in the field of drug discovery and medical research; pharmaceutical product evaluation; consulting services in the field of pharmaceutical product development and design; product quality evaluation for assessing the efficiency of pharmaceuticals; information technology consulting services relating to installation, maintenance and repair of computer software used in the pharmaceutical industry; providing medical and scientific research information in the field of pharmaceutical clinical trial results; provision of information and data relating to pharmaceutical research and development; research and development in the field of drug discovery and drug rescue; providing information, advisory and consultancy services regarding information technology services relating to installation, maintenance and repair of computer software used in the pharmaceutical industry, all of the aforesaid services also provided online via a database or the Internet; laboratory services for the production of pharmaceuticals; laboratory research services relating to pharmaceuticals; computer assisted product design in the field of chemistry and pharmaceuticals; research services in the field of bioinformatics; research services in the field of cheminformatics; research services in the field of molecule design; computer-assisted research services in the field of molecule design; computer-assisted research services in the field of chemical structure; consultancy relating to pharmaceutical research and development; information, advisory and consultancy services relating to all of the aforesaid services | ACTIVE | — |
| 044 | Medical analysis services relating to the treatment of persons; Medical laboratory analysis services relating to the treatment of persons | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ignota Labs Limited
- Other trademarks owned by Ignota Labs Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IGNOTA LABS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 2, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 2, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 1, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 26, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 30, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2026 | NWAP | NEW APPLICATION ENTERED | — |